TickerGuard
Buy Day today: Neutral (52) Mixed market breadth · major macro event coming up
OVID

Ovid Therapeutics Inc

Healthcare · Biotechnology

2.50$ -2.0% vs. previous close Closing price · As of: Sep 30, 2026

Statements

Balance Sheet

Ovid Therapeutics Inc (OVID) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 232 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet OVID
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
125 144 132 118 103 92 82 77 64 151 226 232
92 110 93 81 66 56 46 42 29 90 160 124
57 27 31 30 15 26 21 28 21 13 94 11
87 106 90 77 63 53 43 38 26 70 156 117
0.2 0.2 0.1 0.2 0.2 0.1 0.0 – – – – –
24 56 53 29 26 24 22 22 19 20 27 22
8.7 11 8.9 14 12 11 9.3 8.9 6.8 8.3 16 10.0
1.2 1.2 1.3 1.3 1.3 1.3 1.4 1.4 1.4 1.4 1.5 1.5
1.2 3.7 3.6 4.7 2.7 3.2 2.0 4.0 1.7 2.0 8.9 4.1
101 88 78 89 76 68 59 56 45 131 198 210
-263 -278 -290 -281 -295 -304 -315 -319 -331 -322 -339 -354
71 71 71 71 71 71 71 71 71 82 74 74

Data as of: September 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?